AR223473A1 - Procedimiento para la obtencion de nuevos conjugados de una prostaglandina con una hormona esteroide - Google Patents

Procedimiento para la obtencion de nuevos conjugados de una prostaglandina con una hormona esteroide

Info

Publication number
AR223473A1
AR223473A1 AR275286A AR27528679A AR223473A1 AR 223473 A1 AR223473 A1 AR 223473A1 AR 275286 A AR275286 A AR 275286A AR 27528679 A AR27528679 A AR 27528679A AR 223473 A1 AR223473 A1 AR 223473A1
Authority
AR
Argentina
Prior art keywords
prostaglandine
procedure
steroid hormone
obtaining new
new conjugates
Prior art date
Application number
AR275286A
Other languages
English (en)
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53009652A external-priority patent/JPS5850236B2/ja
Priority claimed from JP10443478A external-priority patent/JPS5845440B2/ja
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Application granted granted Critical
Publication of AR223473A1 publication Critical patent/AR223473A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
AR275286A 1978-01-31 1979-01-25 Procedimiento para la obtencion de nuevos conjugados de una prostaglandina con una hormona esteroide AR223473A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53009652A JPS5850236B2 (ja) 1978-01-31 1978-01-31 プロスタグランジン類↓−ステロイドホルモン結合体
JP10443478A JPS5845440B2 (ja) 1978-08-29 1978-08-29 プロスタグランジン誘導体とその製造方法及び薬剤

Publications (1)

Publication Number Publication Date
AR223473A1 true AR223473A1 (es) 1981-08-31

Family

ID=26344419

Family Applications (1)

Application Number Title Priority Date Filing Date
AR275286A AR223473A1 (es) 1978-01-31 1979-01-25 Procedimiento para la obtencion de nuevos conjugados de una prostaglandina con una hormona esteroide

Country Status (16)

Country Link
US (1) US4198405A (es)
AR (1) AR223473A1 (es)
AU (1) AU519132B2 (es)
CA (1) CA1125742A (es)
CH (1) CH639668A5 (es)
DE (1) DE2900061C2 (es)
DK (1) DK159455C (es)
ES (1) ES477216A1 (es)
FI (1) FI68811C (es)
FR (1) FR2422686A1 (es)
GB (1) GB2015528B (es)
IL (1) IL56430A (es)
IT (1) IT1110751B (es)
NL (1) NL187485C (es)
NO (1) NO151087C (es)
SE (5) SE441006B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318908A (en) * 1979-12-06 1982-03-09 Kureha Kagaku Kogyo Kabushiki Kaisha Methylated prostaglandin derivatives
US4784960A (en) * 1981-09-24 1988-11-15 Peter S. Brune Process for preparation of control for use in progesterone receptor
US4423151A (en) * 1981-09-24 1983-12-27 Peter S. Brune Process for preparation of control for use in estrogen receptor tests
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
CN1906206A (zh) * 2004-01-15 2007-01-31 沃纳奇尔科特公司 雌二醇的二－甾族前体药物
MXPA06007851A (es) * 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de etinil estradiol.
WO2007024338A2 (en) * 2005-07-12 2007-03-01 Warner Chilcott Company, Inc. 3 -ester prodrugs of ethynylestradiol
US20070015741A1 (en) * 2005-07-12 2007-01-18 James Keown Novel prodrugs of estradiol
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839409A (en) * 1958-05-28 1974-10-01 Kemiska Inst Karolinska I Pge3 esters and alkanoates
US3732261A (en) * 1971-12-03 1973-05-08 Nelson Res & Dev Steroid compounds
JPS5829318B2 (ja) * 1974-03-11 1983-06-22 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ホウホウ

Also Published As

Publication number Publication date
FI790281A (fi) 1979-08-01
SE8305322D0 (sv) 1983-09-29
SE441006B (sv) 1985-09-02
SE8305324D0 (sv) 1983-09-29
DK6179A (da) 1979-08-01
CH639668A5 (de) 1983-11-30
FI68811B (fi) 1985-07-31
SE448870B (sv) 1987-03-23
SE8305321D0 (sv) 1983-09-29
SE8305322L (sv) 1983-09-29
DK159455C (da) 1991-03-18
NO790297L (no) 1979-08-01
NL7900071A (nl) 1979-08-02
GB2015528B (en) 1982-10-27
SE8305321L (sv) 1983-09-29
GB2015528A (en) 1979-09-12
SE8305323D0 (sv) 1983-09-29
SE448873B (sv) 1987-03-23
CA1125742A (en) 1982-06-15
NO151087C (no) 1985-02-06
US4198405A (en) 1980-04-15
IL56430A0 (en) 1979-03-12
SE8305324L (sv) 1983-09-29
SE7900086L (sv) 1979-08-01
SE8305323L (sv) 1983-09-29
AU4254578A (en) 1979-08-09
NL187485C (nl) 1991-10-16
IT1110751B (it) 1986-01-06
NL187485B (nl) 1991-05-16
NO151087B (no) 1984-10-29
DK159455B (da) 1990-10-15
FR2422686B1 (es) 1982-11-19
ES477216A1 (es) 1980-03-01
IL56430A (en) 1984-03-30
DE2900061C2 (de) 1982-04-01
DE2900061A1 (de) 1979-08-02
IT7919091A0 (it) 1979-01-05
SE448871B (sv) 1987-03-23
FR2422686A1 (fr) 1979-11-09
SE448872B (sv) 1987-03-23
AU519132B2 (en) 1981-11-12
FI68811C (fi) 1985-11-11

Similar Documents

Publication Publication Date Title
ES483077A0 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
GB2028336B (en) Steroid hormone-antitumour drug conjugates
DK103679A (da) Koaksialkabel-forbindelsesled
AR224186A1 (es) Procedimiento para preparar una hidantoina
MX6888E (es) Procedimiento de preparacion de una composicion catalitica
AR223473A1 (es) Procedimiento para la obtencion de nuevos conjugados de una prostaglandina con una hormona esteroide
RO80716A (ro) Procedeu de preparare a unor pirolidinilbenzamide
ES487847A0 (es) Un procedimiento para preparar nuevas fenetanolaminas
MX148361A (es) Mejoras a fleje para conexiones sin sello
IT1121432B (it) Strutture a sbalzo
MX148811A (es) Sujetador mejorado para una estructura de guia
AR212144A1 (es) Dispositivo de soporte para una articulacion cruciforme
ES482790A0 (es) Un procedimiento para obtener una formulacion de goma de polisacarido terapeuticamente util
DK136679A (da) Antiinflammatoriske corticosteroider
IT1106023B (it) Busta reyersibile
ES493761A0 (es) Un procedimiento para preparar benzoxazepinas
BR7902741A (pt) Cobertura para terminal tubular
DK513379A (da) Samlestykke for roerformede strukturer
SE7901100L (sv) Anti-inflammatorisk steroid
AR227873A1 (es) Un procedimiento de isomerizacion de derivados de vinil-3-piperidina
ES489590A0 (es) Un procedimiento para preparar arilalquil- y ariloxi-alquil-fosfonatos
RO77552A (ro) Procedeu de preparare a unor derivati izochinolinici
AR224173A1 (es) Procedimiento para obtener nuevas cetoaminas cicloalifaticas
ES489647A0 (es) Un procedimiento para la preparacion de un derivado de cefa-losporina
BR7904497A (pt) Estrutura para teares